Welcome to our dedicated page for Pheton Holdings SEC filings (Ticker: PTHL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. Securities and Exchange Commission filings for Pheton Holdings Ltd (PTHL), a Cayman Islands healthcare solution provider focused on treatment planning systems for brachytherapy and related products and services. As a foreign private issuer, the company files an annual report on Form 20-F and furnishes current reports on Form 6-K to disclose financial information and material corporate events.
Through Pheton’s SEC filings, readers can review unaudited interim condensed consolidated financial statements, which have been furnished on Form 6-K for specified periods. These filings include financial statements and accompanying notes, as well as Inline XBRL data files that structure key financial information for analysis.
The company’s 6-K reports also document corporate governance and organizational changes, such as the appointment and resignation of independent directors, the engagement of an independent registered public accounting firm, and the furnishing of notices and proxy statements for its annual general meeting of shareholders. Certain filings include updated memorandum and articles of association, reflecting changes associated with the corporate name iTonic Holdings Ltd.
Investors can find details on capital markets and transaction activity in Pheton’s filings. The company has reported its initial public offering on the Nasdaq Capital Market, advisory services agreements related to mergers and acquisitions strategies, and stock purchase agreements to acquire equity interests in healthcare technology targets, including iTonic Corporation and a company established to develop and commercialize advanced medical device technologies. These reports describe consideration structures involving newly issued Class A ordinary shares and warrants, as well as regulatory exemptions relied upon for unregistered sales of securities.
Filings further disclose Nasdaq listing compliance matters, including a notice from the Nasdaq Listing Qualifications Department regarding non-compliance with the minimum bid price requirement and the associated compliance period. In addition, a current report describes Pheton’s plan to change its corporate name to iTonic Holdings Ltd and its Nasdaq ticker symbol from "PTHL" to "ITOC," explaining that these changes reflect a new business strategy and future development plans.
On Stock Titan, these SEC documents are updated as they are made available through EDGAR, and AI-powered tools can help summarize lengthy filings such as Form 20-F annual reports or detailed Form 6-K exhibits. Users can quickly identify key points about Pheton’s financial condition, acquisitions, governance changes, and listing status, and can also review disclosures related to equity issuances and warrant arrangements. For those researching the historical PTHL ticker and the transition to ITOC, this filings archive offers a structured view of how the company’s regulatory record has developed over time.
Pheton Holdings Ltd is furnishing unaudited interim condensed consolidated financial statements for the six months ended June 30, 2025, in a report as a foreign private issuer. These statements, attached as Exhibit 99.1, cover the six-month periods ended June 30, 2024 and 2025 and provide a detailed view of the company’s mid-year financial position and operating results.
Pheton Holdings Ltd has appointed Fortune CPA, Inc. as its independent registered public accounting firm under an engagement letter dated December 8, 2025. The appointment was approved by the company’s audit committee of the board of directors, confirming board-level authorization of Fortune CPA’s role as the external auditor for the company.
Pheton Holdings Ltd (PTHL) submitted a Form 6-K related to its 2025 Annual General Meeting of Shareholders. The filing primarily serves to furnish key shareholder materials for that meeting.
The submission includes the notice and proxy statement for the annual meeting, as well as the Third Amended and Restated Memorandum of Association and Third Amended and Restated Articles of Association of iTonic Holdings Ltd. The report is signed by Chief Executive Officer and Chairman Jianfei Zhang on behalf of the company.
Pheton Holdings Ltd reported governance changes. Independent director Edward C Ye resigned effective immediately for personal reasons, with no disagreement cited. The board appointed Richard Wee Yong Seow as an independent director, and named him to the Audit, Nomination & Corporate Governance, and Compensation Committees. He will replace Swee Leng Seng as chair of the Compensation Committee, while Mr. Swee Leng Seng becomes chair of the Audit Committee. The Company states Mr. Seow meets Nasdaq and SEC independence standards, and Mr. Swee Leng Seng is an SEC-defined “audit committee financial expert.” The Company entered into an indemnification agreement with Mr. Seow.
Pheton Holdings Ltd (PTHL) reported it received a Nasdaq notice that its Class A ordinary shares failed the minimum bid price requirement under Listing Rule 5550(a)(2) after trading below $1.00 for 30 consecutive business days. The notice does not trigger immediate delisting, and the shares continue trading under “PTHL.”
The company has 180 calendar days, until April 20, 2026, to regain compliance. If the closing bid is at least $1.00 for a minimum of 10 consecutive business days during this period, Nasdaq will confirm compliance. If compliance is not regained by that date, Pheton may qualify for an additional 180‑day grace period if it meets other Nasdaq Capital Market initial listing standards (except bid price) and notifies Nasdaq of its plan to cure, which may include a reverse stock split.
Pheton Holdings Ltd entered into a stock purchase agreement to acquire 51% of the outstanding shares of iTonic Corporation, a provider of a home health platform that integrates medication dispensing, supply chain management, virtual care, and patient monitoring. As consideration, Pheton agreed to issue 4,000,000 newly issued Class A ordinary shares and warrants to purchase up to 3,000,000 Class A ordinary shares to the selling shareholders.
The consideration shares will be locked up and released only if iTonic meets agreed performance milestones tied to sales volume and sales revenue, measured quarterly beginning January 1, 2026. The warrants are also subject to milestone-based exercisability. The transaction is subject to customary closing conditions and may not close if those conditions are not satisfied.
The consideration shares, the warrants, and the Class A ordinary shares issuable upon warrant exercise will be issued in a private placement, relying on exemptions from registration under Section 4(a)(2) and Rule 506(b) of Regulation D and Regulation S for offers and sales outside the U.S.
FAQ
What is the current stock price of Pheton Holdings (PTHL)?
What is the market cap of Pheton Holdings (PTHL)?
